HIMS
HIMS THROUGH LABOR DAYThis is my speculative technical analysis of what I believe could unravel with $HIMS.
$45.00 has been crossed twice, and I believe this is where the line on the sand is drawn. A Strong close above this mark and we could see $47.40, $48.94, and then a gap fill to $50.00 which is a big psychological level.
An area where I would expect some price consolidation before picking direction once again.
New Bear Market? Heavy Tech SelloffToday the markets were shattered by weakness in mega cap tech.
All major leading companies in the QQQ were severely down.
We saw the majority of the S&P 500 sectors green with health care leading the charge.
Despite all indices closing negative this was not a full fledge market sell.
Commodities were hit across the board. Gold, Nat gas, Oil, Uranium, Silver were all down.
It seems the market is de risking into J Powell Jackson Hole meeting on Thursday / Friday.
Today we closed out NASDAQ:MSFT NASDAQ:PLTR short & trimmed AMEX:MSOS puts for over 105%
We were very active on the option and swing trading side of the market.
Hims & Hers Health (HIMS) AnalysisHims & Hers Health NYSE:HIMS is a leading telehealth platform delivering personalized care in sexual health, hair loss, dermatology, mental health, and weight loss.
Growth Drivers:
Weight Loss Service Momentum ⚡
Q1 2025 launch of a GLP-1 prescription program with coaching & diagnostics has unlocked a major new revenue stream.
Strong adoption is fueling accelerated growth.
Subscriber & Revenue Growth 📊
Q2 2025 subscribers surged 31–38% YoY to 2.4M.
Monthly revenue per subscriber jumped 30% to $74, reflecting deeper engagement.
Operational Leverage 🤖
AI-driven care and pharmacy automation are enhancing scalability and margins.
Partnership expansions are broadening reach and improving efficiency.
Investment Outlook:
Bullish Case: We remain bullish above $54.00–$55.00, supported by high-margin recurring revenue and strong subscriber momentum.
Upside Potential: Target: $110.00–$115.00, driven by continued adoption of GLP-1 programs, tech-enabled scalability, and strategic partnerships.
📢 HIMS—Scaling Digital Healthcare with AI, Innovation, and Strong Subscriber Economics. #HIMS #Telehealth #GLP1 #DigitalHealth #GrowthStocks
HIMS Bearish Breakdown — Weekly Put Option Setup🚨 HIMS Bearish Breakdown — Weekly Put Option Setup**
Hims & Hers (HIMS) shows strong institutional selling pressure with a clear breakdown below key support levels. Multiple models (Google Gemini, DeepSeek, Claude) confirm bearish momentum fueled by heavy volume, insider selling, and ongoing legal concerns. While a short-term bounce is possible, the bias remains firmly bearish into next week.
**🛠 Trade Setup:**
* **Instrument:** HIMS
* **Direction:** PUT (SHORT)
* **Strike:** \$48.00
* **Expiry:** 2025-08-15
* **Entry Price:** \$0.94
* **Profit Target:** \$1.35 (50% gain)
* **Stop Loss:** \$0.40
* **Size:** 1 contract
* **Entry Timing:** Market open
* **Confidence:** 75%
**📊 Key Factors:**
* Heavy institutional distribution
* Breakdown of weekly support
* High selling volume with low VIX environment (favorable for directional trades)
* Lawsuits + insider selling adding downside risk
**⚠ Risks:**
* Rising daily RSI could spark a temporary bounce
* Event-driven volatility could shift trade direction quickly
---
**#HIMS #OptionsTrading #PutOptions #WeeklyOptions #BearishSetup #SupportBreakdown #TechnicalAnalysis #TradingView #InstitutionalSelling #VolatilityPlay #SwingTrade #OptionsStrategy**
Grok Bets Big on HIMS $60 Calls
**HIMS \$60C in Play! Mixed Models, But Grok Goes Bullish 💥 \ **
---
### 🧠 TradingView-Ready Caption:
**HIMS Weekly Trade Alert 🚨 | Aug 8 Expiry**
> While most models stay cautious, **Grok/xAI pulls the trigger** on a bullish call. Weekly RSI rising, volume weak but stable. Entry at market open, eyeing that \$60 breakout.
📈 **Trade Setup:**
* **Instrument:** \ NYSE:HIMS
* **Direction:** CALL (Bullish)
* **Strike:** \$60.00
* **Expiry:** Aug 8, 2025
* **Entry Price:** \$7.00
* **Target:** \$8.00
* **Stop Loss:** \$3.50
* **Confidence:** 65%
🧊 Risk: Gamma decay with 3 DTE, mixed signals across models.
🔥 Reward: Only Grok model signals upside — the contrarian bet.
---
### 🏷️ Suggested Tags:
`#HIMS #OptionsTrading #CallOption #HIMS60C #TradingSetup #StockMarket #TechnicalAnalysis #GrokAI #WeeklyTrade #BullishPlay #TradingView #RSI #GammaRisk #EventRisk #SPY #AIModels`
HIMS WEEKLY TRADE IDEA (7/29/25)*
**💊 HIMS WEEKLY TRADE IDEA (7/29/25)**
**🔥 Bullish Flow + Rising RSI + Institutional Volume**
**📈 Trade Setup**
• **Stock**: \ NYSE:HIMS
• **Direction**: CALL (LONG)
• **Strike**: \$64.00
• **Entry**: \$0.92
• **Target**: \$1.38
• **Stop**: \$0.46
• **Size**: 2 contracts
• **Expiry**: Aug 1, 2025 (3DTE)
• **Confidence**: 80%
• **Entry Timing**: Market Open
---
**🧠 Why This Trade?**
✅ **Call/Put Ratio = 1.37** → Bullish sentiment
✅ **RSI Daily: 65.2 / Weekly: 61.3** → Momentum building
✅ **1.8x Weekly Volume Surge** → Institutional accumulation
✅ **\$64C OI = 2,616** → High liquidity + interest
⚠️ **Gamma Risk + Fast Decay** → Time-sensitive play
---
**🎯 Strategy**
→ Play the momentum spike into expiry
→ Exit quickly on profit target or 50% stop
**#OptionsTrading #HIMS #SwingTrade #EarningsPlay #TradingViewSetup #FlowTrade**
HIMS WEEKLY BULLISH PLAY — 07/23/2025
🩺 HIMS WEEKLY BULLISH PLAY — 07/23/2025
📈 Momentum Up, Flow Bullish, Time Tight — Let’s Ride It
⸻
🔍 MARKET SNAPSHOT
5-model AI consensus = ✅ BULLISH
Why?
• 📈 Weekly RSI = 58.2 (Rising) — Clear momentum
• ⚖️ Call/Put Ratio = 1.63 — Big call volume (45K+)
• 📉 Volume = 0.9x — ⚠️ Slight institutional hesitation
• 🌪️ VIX = 16.0 — Low volatility = smoother execution
⸻
🎯 TRADE IDEA — CALL OPTION PLAY
{
"instrument": "HIMS",
"direction": "CALL",
"strike": 58.00,
"entry_price": 0.86,
"profit_target": 1.72,
"stop_loss": 0.43,
"expiry": "2025-07-25",
"confidence": 75%,
"entry_timing": "Open",
"size": 1 contract
}
⸻
📊 TRADE PLAN
🔹 🔸
🎯 Strike 58 CALL
💵 Entry 0.86
🎯 Profit Target 1.72 (+100%)
🛑 Stop Loss 0.43 (tight risk)
📅 Expiry July 25 (2DTE)
⚡ Confidence 75%
📈 Size Suggestion Risk 2–3% of capital
⚠️ Key Risks Low volume + high gamma exposure
⸻
🧠 MODEL TAKEAWAYS
✅ RSI and momentum are clearly aligned upward
✅ Call flow = bullish commitment
⚠️ Volume is light → watch for momentum stalls
⚠️ Gamma risk = manage tight, exit fast
⸻
💬 Drop a 🧠 if you’re tracking
📈 Drop a 💥 if you’re in this call
🛎️ Trade tight — expiration Friday, HIMS is moving on momentum not mass
#HIMS #OptionsTrading #CallOptions #BullishPlay #MomentumTrade #ZeroDTE #GammaScalp #AITrading #HealthcareStocks
My buy view for Hims & Hers stock. My buy view for Hims & Hers stock.
Overall, I believe this asset is still in a bullish direction. I remember hoping into accummulating this stock when it dropped from $64 to $41 at the open of market on 23/6/2025 which I sold off when it hit $50.
However, I still hold a strong buy bias with my entry and exit showing on my chart (analysis).
Please trade with care as I still look forward to $64 per share for this stock long-term.
Please, kindly like, share your thoughts via comment and follow me for more.
HIMS · 4H — Symmetrical Triangle Breakout Targeting $55 → $60Setup Breakdown
HIMS is forming a symmetrical triangle consolidation, with price tightening between rising support and descending resistance.
The structure follows a previous impulsive move, suggesting this is likely a bullish continuation pattern.
Volume is contracting — typical for pre-breakout setups — and price is holding above a key short-term rising trendline.
A breakout above $52–53 could initiate a fast move into the next resistance band.
---
🎯 Target Zone
🎯 Target Level Reason
Target-1 $55.50 (38.2% Fib) Volume gap fill + first resistance from prior consolidation range. A clean spot for partial profits.
Target-2 $60.00 (50% Fib) Strong historical resistance + Fibonacci confluence. Ideal level to take the rest of the position or trail a runner.
---
🛠️ Trade Plan (Example)
Component Action
Trigger Long on a confirmed breakout above $52 with volume ≥ 20-SMA
Entry Add-on Pullback retest of broken triangle resistance ($52) acting as new support
Stop-loss Close < $49.50 — invalidates the triangle
TP-1 $55.50 — take 50–70% off, move stop to breakeven
TP-2 $60.00 — exit or leave a small runner in case of further breakout
---
⚠️ Risk Notes
Earnings date approaching – trade may need to be closed or hedged before volatility spikes.
Break below $49.50 invalidates the pattern and opens risk to $46 or lower.
Watch for volume confirmation — fakeouts can occur if breakout lacks momentum.
---
✅ Checklist
Triangle structure with strong trendline support
Low-volume zone between $53–60 favors fast expansion
Targets align with Fib + volume profile
Risk clearly defined
Earnings awareness in place
> Disclaimer: This is not financial advice. Trade your own plan and manage risk appropriately.
HIMS 1D — This pattern didn’t cook for nothingOn the daily chart of Hims & Hers Health, we’re looking at a textbook cup with handle formation — not just a pattern, but a structure backed by time, volume, and classic price behavior. The base of the cup formed steadily from February to May 2025, and as soon as the curve was complete, price transitioned into a tight consolidation — the "handle" that often masks real accumulation.
Right now, price is testing the resistance area. And it’s not just floating up there — it’s coming in hot: price has already broken through EMA 20/50/100/200 and SMA 50/200. That’s a full stack flip. This isn’t sideways noise — it’s a structural shift in control.
Volume is starting to build as price rises, confirming that demand is real and institutional positioning likely active. We’re watching a breakout zone above the handle — and when that breaks, the structure unlocks with a clear target: $107.25, roughly a 2x move from current levels.
This setup isn’t noise. It’s a long-cooked formation that’s now about to boil over. If the handle holds and price breaks through — the rest is just follow-through.
HIMS puked up its Wegovy today!Hims & Hers Health
HIMS
shares were down more than 34.63% in Monday trading, while Novo Nordisk
NVO stock was down over 5% after Novo Nordisk said it has halted its collaboration with Hims & Hers on the sale of weight loss drugs, including Wegovy.
The two companies launched a collaboration in April to bundle Wegovy through Hims & Hers' telehealth platform.
Novo Nordisk said direct access to the drug would no longer be available through Hims & Hers Health because the company "has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk."
This stock failed to catch a bid despite the equity markets strong.
$HIMS setting up for its next big move—here’s what I’m watching!🔥 NYSE:HIMS setting up for its next big move—here’s what I’m watching! 🔥
📉 Eyeing momentum down to $44-$48, and I’m not mad about it!
🔄 That flip from resistance to support is key for long-term price growth.
🚀 Bull flag breakout could come sooner—stay locked in! Keeping an eye on it all for the next trade entry on this beast!
💬 What’s your take? Are we bouncing or breaking out? Drop your thoughts below! ⬇️
HIMS – Technically and Fundamentally Strong for Mid-to-Long TermTechnical Analysis
HIMS is trading in a clear ascending channel since 2023.
On the daily chart, a “cup and handle” formation has completed, with a confirmed breakout above the neckline ($55–$57 area).
The price is consolidating near the breakout point – classic behavior before a continuation move.
Target projection from the cup pattern is $170+, implying a 200%+ upside potential.
The stock also respects the upper trendline of the long-term channel, reinforcing bullish structure.
Fundamental Strength:
Telemedicine megatrend: Digital health is booming. HIMS is one of the few well-established D2C players in the U.S. market.
Revenue growth: Annual revenue growth exceeds 40% YoY, a sign of operational efficiency and demand.
Sticky subscription model: Over 1.5 million active subscribers — solid base for recurring revenue and LTV.
Valuation upside: Still undervalued relative to sector peers despite recent rally.
Scalable tech stack: Strong backend, customer acquisition systems, and vertically integrated infrastructure support further expansion.
Conclusion: HIMS offers an attractive risk–reward setup for swing traders and long-term investors alike
HIMS Weekly Options Outlook — June 3, 2025📉 HIMS Weekly Options Outlook — June 3, 2025
🚨 AI Model Consensus: Moderately Bearish into June 6 Expiry
🧠 Model Overview
🔹 Grok (xAI)
Bias: Neutral
Setup: Bearish short-term, bullish long-term; mixed outlook
Trade: No action — lacks edge
Confidence: 35%
🔹 Claude (Anthropic)
Bias: Moderately Bearish
Setup: Below EMAs, bearish MACD; cautious sentiment
Trade: Buy $52P @ $0.94 → PT $1.88+, SL $0.56
Confidence: 72%
🔹 Llama (Meta)
Bias: Moderately Bearish
Setup: Post-run fractal pullback, mixed but leaning down
Trade: Buy $52P → PT +20%, SL −50%
Confidence: 70%
🔹 Gemini (Google)
Bias: Moderately Bearish
Setup: Clean break under EMAs, MACD/RSI confirm weakness
Trade: Buy $50P @ ~$0.47 → PT 100%, SL 50%
Confidence: 65%
🔹 DeepSeek
Bias: Moderately Bearish
Setup: Breakdown across timeframes; skewed put flow
Trade: Buy $50P @ $0.45 → PT $0.70, SL $0.32
Confidence: 65%
✅ Consensus Summary
📉 4 of 5 models recommend bearish weekly puts
🔻 Clear breakdown under EMAs with supportive MACD/RSI signals
🧲 Max Pain at $55 could cause late-week pullback or stall
🎯 Preferred strategy: OTM naked puts with high ROI potential
🎯 Recommended Trade Setup
💡 Strategy: Weekly Bearish Put Play
🔘 Ticker: HIMS
📉 Direction: PUT
🎯 Strike: $52
💵 Entry: $0.94 (ask)
🎯 Profit Target: $1.70 (+80%)
🛑 Stop Loss: $0.56 (−40%)
📏 Size: 1 contract
📅 Expiry: 2025-06-06
⏰ Entry Timing: Market Open
📈 Confidence: 70%
⚠️ Risk Factors to Watch
🧲 Max pain at $55 could slow breakdown or cause snapback
🔻 $52 support zone may cause consolidation or chop
📉 Falling VIX = compressed premiums, slower option movement
⌛ Theta accelerates into Thursday/Friday — exit early if flat
HIMS 20SMA Trend Contiuation PULLBACK SETUP NYSE:HIMS – Momentum Reload at 20 SMA After Massive Run
NYSE:HIMS has been one of the hottest stocks in the market, and it’s giving us a textbook trend continuation pullback setup — right into the sweet spot.
🔹 Pullback to the 20 SMA
• After a huge run, NYSE:HIMS finally gave us a controlled pullback to the 20 SMA, where it based for multiple days.
• Today, it remounted the 9 EMA — a key trigger in my swing strategy for momentum re-entry.
🔹 Why This Setup Works
• Momentum names don’t stay down long — this was just a reset.
• Even with the market shaky today, NYSE:HIMS closed strong — up 8% while the rest of the tape faded.
• This setup is all about getting back into strength with low risk.
My Trade Plan:
1️⃣ Entry: Took a position on today’s remount of the 9 EMA.
2️⃣ Stop: Just under the 20 SMA — tight, well-defined risk.
3️⃣ Target: First target is a move back into the previous highs — if it breaks, we trail for continuation.
🧠 This is my bread-and-butter swing entry — clean, controlled, and full of momentum potential.
Update on Nuclear Stocks SMR, OKL0 + NEW IDEAS VRT, TSLA OKLO, SMR going through the roof. NNE is trailing today. Sold out most of the RKLB.
Lets go over the SPY, QQQ which are flagging now after holding support.
Liking this VRT and LTBR AND LUNR for potential swings along with HIMS!
Lets dig into the charts and see whats up!